We are live on
!
Find out more
PLC
Peapod Lane Capital Portfolio holdings
AUM
$122M
1-Year Est. Return
67.29%
This Fund
S&P 500
This Quarter
Est. Return
+9.94%
1 Year Est. Return
+67.29%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$122M
AUM Growth
+$4.36M
(+3.7%)
Cap. Flow
-$1.05M
Cap. Flow
% of AUM
-0.86%
Top 10 Holdings %
Top 10 Hldgs %
30.92%
Holding
68
New
9
Increased
32
Reduced
20
Closed
6
Top Buys
| 1 |
Standard BioTools
LAB
|
+$2.46M |
| 2 |
SEG
Seaport Entertainment Group
SEG
|
+$1.93M |
| 3 |
Arq
ARQ
|
+$1.75M |
| 4 |
Kelly Services Class A
KELYA
|
+$1.62M |
| 5 |
Inogen
INGN
|
+$1.6M |
Top Sells
| 1 |
iShares Russell 2000 ETF
IWM
|
+$4.86M |
| 2 |
Alto Neuroscience
ANRO
|
+$4.52M |
| 3 |
Biglari Holdings Class B
BH
|
+$4.12M |
| 4 |
Alto Ingredients
ALTO
|
+$2.66M |
| 5 |
CLYM
Climb Bio
CLYM
|
+$2.64M |
Sector Composition
| 1 | Healthcare | 20.82% |
| 2 | Industrials | 20.45% |
| 3 | Consumer Discretionary | 16.52% |
| 4 | Consumer Staples | 9.77% |
| 5 | Real Estate | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
MaxCyte
MXCT
$152M
| $926K | 0.76% |
+1,332,193
| New | +$1.24M |
|
|
KZR
52
DELISTED
Kezar Life Sciences
KZR
| $925K | 0.76% |
126,692
-7
| -0% | -$46 |
|
53
Zentalis Pharmaceuticals
ZNTL
$340M
| $835K | 0.68% |
366,868
-81,993
| -18% | -$212K |
|
54
Methode Electronics
MEI
$618M
| $774K | 0.63% |
+140,642
| New | +$1.03M |
|
|
CLYM
55
Climb Bio
CLYM
$758M
| $740K | 0.61% |
108,878
-457,114
| -81% | -$2.64M |
|
56
Seer Inc
SEER
$119M
| $736K | 0.6% |
438,581
-31
| -0% | -$57 |
|
57
DocGo
DCGO
$63.7M
| $698K | 0.57% |
+1,129,194
| New | +$850K |
|
58
Metagenomi Therapeutics
MGX
$49.7M
| $683K | 0.56% |
516,761
+19,108
| +4% | +$29.7K |
|
59
Fuel Tech
FTEK
$49.9M
| $582K | 0.48% |
478,842
+119,199
| +33% | +$165K |
|
|
BCYC
60
Bicycle Therapeutics
BCYC
$294M
| $550K | 0.45% |
+121,106
| New | +$692K |
|
61
Kyverna Therapeutics
KYTX
$483M
| $336K | 0.28% |
40,404
-143,416
| -78% | -$1.19M |
|
62
AN2 Therapeutics
ANTX
$171M
| $207K | 0.17% |
59,854
-533,542
| -90% | -$1.1M |
|
|
63
Biglari Holdings Class B
BH
$1.21B
| – | – |
-12,399
| Closed | -$4.12M |
|
|
FSP
64
Franklin Street Properties
FSP
$50.7M
| – | – |
-614,235
| Closed | -$581K |
|
65
Geospace Technologies
GEOS
$94.3M
| – | – |
-37,817
| Closed | -$639K |
|
|
66
iShares Russell 2000 ETF
IWM
$82.3B
| – | – |
-19,758
| Closed | -$4.86M |
|
67
Scholastic
SCHL
$863M
| – | – |
-27,344
| Closed | -$810K |
|
|
68
Alto Neuroscience
ANRO
$976M
| – | – |
-253,992
| Closed | -$4.52M |
|
Similar funds
VAM
TFS
HRC
WRCM
SO
MFC
PWP
KGC